P. Thomaré

Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study

A. Lassalle, P. Thomaré, Clémentine Fronteau et al. · Annals of Oncology · 2015 · 45 citations

Home Administration, Hematological Malignancy, Oncology +7

Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study

Maxime Jullien, Sabrina Trudel, Benoît Tessoulin et al. · Annals of Hematology · 2019 · 33 citations

Hematological Malignancy, Single-agent Daratumumab, Medicine +4

Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer

Jean‐Yves Douillard, Jaafar Bennouna, Fabienne Vavasseur et al. · Cancer Immunology Immunotherapy · 2000 · 31 citations · Full text

Oncology, Gastrointestinal Oncology, Medicine +6

Silent hypersensitivity to<i>Escherichia coli</i>asparaginase in children with acute lymphoblastic leukemia

Marion Strullu, Nadège Corradini, Marie Audrain et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 30 citations

Silent Hypersensitivity, Allergy, Allergy Medicine +11

Sensitive micromethod for column liquid chromatographic determination of fluoxetine and norfluoxetine in human plasma

P. Thomaré, Kang Wang, V. Van Der Meersch-Mougeot et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1992 · 29 citations

Sensitive Micromethod, Gas Chromatography, Medicine +9